DPBIO

High-throughput droplet microfluidic solutions for antibody discovery and research

BiotechnologyLife Sciences dp-bio.com ↗

Company facts

Founded
2018
Employees
100
Headquarters
United States
Type
Private
Funding
Series B · $13.9M · 2024